https://www.bccresearch.com/index/rss/code/pharmaceuticalshttps://www.bccresearch.com/public/public/images2017/logo.png https://www.bccresearch.com/index/rss/code/pharmaceuticalsPharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.en-usN/Ainfo@bccresearch.com 30Copyright (C) 2022 bccresearch.comThe report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/emerging-drugs-markets.htmlThe global market for lung cancer therapeutics is expected to grow from $32.5 billion in 2025 and is projected to reach $49.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/lung-cancer-therapeutics-markets-report.htmlThis report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/bispecific-antibodies-market.htmlThe global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/neuroprotective-agents-therapeutic-applications-and-global-markets.htmlThe global market for radioligand therapeutics in cancer treatment is estimated to grow from $2.6 billion in 2025 to $4.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/radioligand-therapeutics-in-cancer-treatment-market.htmlThe global market for monoclonal antibodies in oncology is expected to grow from $129.3 billion in 2025 and is projected to reach $228 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/monoclonal-antibodies-market-for-oncology.htmlThe global market for cannabis was valued at $45.6 billion in 2025 and is projected to reach $79.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/cannabis-market-report.htmlThe global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/oncology-biosimilars-market.htmlThe global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/advanced-drug-delivery-administration.htmlThis report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025andndash;2030).info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/glp-1-analogues-market.htmlThe global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/immunotherapy-drugs-market.htmlThe global market for Artificial Intelligence (AI) in Clinical Trials was valued at $2 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $6.5 billion by 2030, at a compound annual growth rate (CAGR) of 22.6% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/artificial-intelligence-in-clinical-trials-market.htmlThe report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/brain-tumor-therapeutics-markets.htmlThe global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-viral-vector-manufacturing-markets-and-technologies.htmlThe global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/hyaluronic-acid-in-healthcare-markets.htmlThis report provides an overview of the global market for targeted alpha therapies for cancer and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/targeted-alpha-therapies-for-cancer-treatment-market.htmlThe global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/therapies-rheumatoid-arthritis-markets-report.htmlThe global market for anti-Parkinsonandrsquo;s drugs is projected to grow from $6.1 billion in 2025 to reach $9.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/anti-parkinson-drugs-global-markets-report.htmlThe global market for infectious disease treatments is expected to grow from $72.5 billion in 2025 and is projected to reach $101 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/infectious-disease-treatments-markets-report.htmlThis report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimerandrsquo;s disease. It includes global revenue ($ million) for base year data of 2024, estimates for 2025, and CAGR forecasts through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/disease-modifying-therapies-for-alzheimers-disease-market.htmlThe global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/allergy-diagnostics-treatments-markets-report.htmlThe global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/otc-drugs-vitamins-dietary-supplements-markets.htmlThis report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/pharmaceutical-drugs-industry-competitive-landscape.htmlThe global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.andnbsp; The North American influenza market is expected to grow from $4.5.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/the-global-influenza-market.htmlThe global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/liver-disease-treatments-global-market-report.htmlThe global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/cancer-immunotherapy-market.htmlThe report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/nanotechnology-cancer-treatment-market-report.htmlThe global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/radiopharmaceuticals-technologies-markets-report.htmlThe global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-cancer-therapeutics-market-emphasis-on-recurrent-and-metastatic-divisions-report.htmlThe global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/personalized-medicine-epigenomics-tech-markets-report.htmlThe global market for high-throughput screening is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/high-throughput-screening-technologies-global-markets.htmlThe global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/neurology-market-research-report.htmlThe global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/pharmaceuticals-research-review.htmlThe global market for Alzheimerandrsquo;s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/alzheimers-disease-therapeutics-diagnostics-markets-report.htmlThe global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/laboratory-animal-models-3D-cultures-organoids.htmlThe global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/rare-disease-diagnostics-market-report.htmlThe global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/breakthrough-therapies-market-report.htmlThe global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/softgel-capsules-market.htmlThe global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-cdmo-market.htmlThe global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/active-pharmaceutical-ingredients-global-markets.htmlThe global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-market-for-contract-research-organization-cro-services.htmlThe global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/oncology-pharmaceuticals-market.htmlThe global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.6 billion in 2024 to $12.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/excipients-in-pharmaceuticals-global-markets.htmlThe global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/antibody-drug-conjugates-markets-report.htmlThe global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-markets-for-contract-pharmaceutical-manufacturing-research-and-packaging.htmlThe global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/drug-device-combinations-markets-report.htmlThe global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/hematological-disorders-diagnostics-markets-report.htmlThe global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/gastrointestinal-therapeutics-markets-report.htmlThe global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/advanced-drug-delivery-systems-tech-markets-report.htmlThe global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/prostate-cancer-technologies-markets-report.html